In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy

Increased mesangial expansion is one of the most characteristic histological changes in diabetic nephropathy (DN). Although the pathogenesis of DN remains unclear, recent studies associate interleukin (IL) 6 with mesangial proliferative glomerulonephritis. To elucidate the expression and localization of IL-6 mRNA in renal tissues of patients with DN, a high-resolution in situ hybridization using digoxigenin-labeled oligonucleotide was performed. Patients were divided into three groups based on light microscopy findings: mild (group 1), moderate (group 2), and severe (group 3) mesangial expansion. The relationship between the expression of IL-6 mRNA and the degree of glomerular mesangial expansion in DN was examined. Individual cells positive for IL-6 mRNA were observed in glomeruli. These cells were mesangial cells, glomerular epithelial cells, and Bowman's capsule. The signal intensity was strongest in tissues from group 2 but was weak in those from groups 1 and 3. Most cells in the area of mesangial proliferation were strongly stained for IL-6 mRNA, and few positive cells were found in the Kimmelstiel-Wilson nodular lesion. In the interstitium, some tubules, particularly atrophic tubules, and some infiltrating cells were positively stained for IL-6 mRNA. The interstitial expression of IL-6 mRNA correlated significantly with the degree of interstitial injury and was remarkable in tissues from groups 2 and 3. We conclude that IL-6 mRNA is expressed by glomerular resident cells and interstitial cells in the renal tissue of patients with DN and that its expression may be associated with mesangial proliferation and may be involved in the tissue injury of DN.

[1]  R. Atkins,et al.  A sensitive method of non-radioactive in situ hybridization for mRNA localization within human renal biopsy specimens: use of digoxigenin labeled oligonucleotides. , 1994, Internal medicine.

[2]  E. Tsilibary,et al.  Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. , 1993, The Journal of clinical investigation.

[3]  K. Matsushima,et al.  In situ expression of cytokines in IgA nephritis. , 1993, Kidney international.

[4]  Y. Yuzawa,et al.  Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[5]  E. Schulze-Lohoff,et al.  Cytokines and mesangial cells. , 1993, Kidney international. Supplement.

[6]  F. Ziyadeh Renal tubular basement membrane and collagen type IV in diabetes mellitus. , 1993, Kidney international.

[7]  M. Kashgarian,et al.  Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion. , 1992, The American journal of pathology.

[8]  R. Bilous,et al.  Cell and Matrix Components of the Glomerular Mesangium in Type I Diabetes , 1992, Diabetes.

[9]  H. Rodemann,et al.  The role of interstitial cells in the progression of renal diseases. , 1992, Journal of the American Society of Nephrology : JASN.

[10]  S. Nishi,et al.  An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. , 1992, Kidney international.

[11]  M. Iwano,et al.  Induction of interleukin 6 synthesis in mouse glomeruli and cultured mesangial cells. , 1992, Nephron.

[12]  D. Troyer,et al.  High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. , 1991, The American journal of physiology.

[13]  B. Berman,et al.  Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. , 1991, The Journal of investigative dermatology.

[14]  L. Gesualdo,et al.  Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[15]  T. Hirano,et al.  Distribution of interleukin-6 in normal and diseased human kidney. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[16]  T. Hirano,et al.  The prognostic significance of urinary interleukin 6 in IgA nephropathy. , 1991, Clinical nephrology.

[17]  D. Suzuki,et al.  Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha 2 plasmin inhibitor complexes in plasma. , 1990, The Journal of diabetic complications.

[18]  T. Sato,et al.  Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. , 1990, Biochemical and biophysical research communications.

[19]  B. Brenner,et al.  Glomerular function in diabetes mellitus. , 1990, Advances in nephrology from the Necker Hospital.

[20]  A. Muraguchi,et al.  Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.

[21]  J. Miyazaki,et al.  IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Chavers,et al.  Mesangial Expansion as a Central Mechanism for Loss of Kidney Function in Diabetic Patients , 1989, Diabetes.

[23]  K. Jung,et al.  Further evidence for tubular dysfunction in insulin dependent diabetes. , 1989, The Journal of diabetic complications.

[24]  K. Konishi,et al.  Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. , 1989, American journal of nephrology.

[25]  C. Abrass,et al.  Phenotypic Expression of Collagen Types in Mesangial Matrix of Diabetic and Nondiabetic Rats , 1988, Diabetes.

[26]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[27]  R. Østerby,et al.  Glomerular Morphology by Light Microscopy in Non-Insulin-Dependent Diabetes Mellitus: Lack of Glomerular Hypertrophy , 1988, Diabetes.

[28]  M. Endoh,et al.  Modified open renal biopsy: results in 934 patients. , 1987, Nephron.

[29]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[30]  L. Chylack,et al.  The Effect of Oxidation on Sorbitol Pathway Kinetics , 1986, Diabetes.

[31]  M. Steffes,et al.  Structural-functional relationships in diabetic nephropathy. , 1984, The Journal of clinical investigation.

[32]  K. Iidaka,et al.  The glomerular mesangium. A quantitative analysis. , 1968, Laboratory investigation; a journal of technical methods and pathology.